Breaking News Instant updates and real-time market news.

VTR

Ventas

$52.06

(0.00%)

, BZUN

Baozun

$44.99

(0.00%)

09:40
05/17/18
05/17
09:40
05/17/18
09:40

Unusually active option classes on open May 17th

Unusual total active option classes on open include: Ventas (VTR), Baozun (BZUN), TakeTwo Interactive Software (TTWO), NetEase (NTES), Cisco (CSCO), Market Vectors Russia (RSX), Seadrill (SDRL), Wal-Mart (WMT), Chesapeake (CHK), and Baidu (BIDU).

VTR

Ventas

$52.06

(0.00%)

BZUN

Baozun

$44.99

(0.00%)

TTWO

Take-Two

$112.91

(0.00%)

NTES

NetEase

$266.00

(0.00%)

CSCO

Cisco

$45.16

(0.00%)

RSX

Market Vectors Russia ETF

$21.69

(0.00%)

SDRL

Seadrill

$0.47

(0.00%)

WMT

Walmart

$86.07

(0.00%)

CHK

Chesapeake

$3.94

(0.00%)

BIDU

Baidu

$283.88

(0.00%)

  • 17

    May

  • 17

    May

  • 18

    May

  • 30

    May

  • 30

    May

  • 01

    Jun

  • 07

    Jun

  • 10

    Jul

VTR Ventas
$52.06

(0.00%)

04/30/18
04/30/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Altria Group (MO) upgraded to Outperform from Sector Perform at RBC Capital with analyst Nik Modi saying while his concerns around the macro backdrop and fundamentals persist, the current valuation of 13-times forward PE is attractive relative to the broader Consumer Packaged Goods category given the company's potential catalysts of more dividend increases tracking higher interest rates and the FDA approval process for IQOS electronic cigarettes. 2. Aaron's (AAN) upgraded to Buy from Hold at Loop Capital with analyst Anthony Chukumba saying he remains "impressed" by Progressive's revenue growth and thinks the unit will benefit from Rent-A-Center's (RCII) "ongoing struggles." 3. Cirrus Logic (CRUS) upgraded to Buy from Hold at Craig-Hallum with analyst Anthony Stoss saying he believes Apple (AAPL) headwinds are already priced into the stock and a relief rally is likely following the company's upcoming earnings this Wednesday. 4. Ventas (VTR) upgraded to Market Perform from Underperform at BMO Capital with John Kim citing a more attractive valuation after the stock price came down another 19% in 2018. 5. New York Times (NYT) upgraded to Overweight from Neutral at JPMorgan with analyst Alexia Quadrani saying she believes digital demand will likely drive further "outsized growth" for New York Times. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/27/18
HDLY
04/27/18
UPGRADE
Target $60
HDLY
Long-Term Buy
Ventas upgraded to Long-Term Buy from Neutral at Hilliard Lyons
Hilliard Lyons analyst John Roberts upgraded Ventas to Long-Term Buy from Neutral following the company's Q1 report. He has a $60 price target on the shares.
04/30/18
BMOC
04/30/18
UPGRADE
BMOC
Market Perform
Ventas upgraded to Market Perform from Underperform at BMO Capital
04/30/18
BMOC
04/30/18
UPGRADE
Target $53
BMOC
Market Perform
Ventas upgraded to Market Perform at BMO Capital on valuation
As reported earlier, BMO Capital John Kim upgraded Ventas (VTR) to Market Perform from Underperform and raised his price target to $53 from $51. Kim cites a more attractive valuation after the stock price came down another 19% in 2018. The analyst also notes that the extension of Ventas' master lease with Brookdale (BKD) "addresses a major 2019 expiration" and buys time to deal with non-performing assets while also reducing the possibility of a dividend cut in the short term.
BZUN Baozun
$44.99

(0.00%)

03/06/18
LYON
03/06/18
DOWNGRADE
LYON
Outperform
Baozun downgraded earlier to Outperform from Buy at CLSA
08/31/17
SBSH
08/31/17
INITIATION
Target $38
SBSH
Buy
Baozun initiated with a Buy at Citi
Target $38.
08/23/17
08/23/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Ultragenyx (RARE) downgraded to Hold from Buy at SunTrust, with analyst Edward Nash slashing his price target to $55 from $105 after the company reported negative topline data from the Phase III trial for Ace-ER for GNE myopathy. Nash is disappointed by this first major clinical setback for the company and removed Ace-ER from his valuation models. 2. Duluth Holdings (DLTH) downgraded to Market Perform from Outperform at Raymond James, with analyst Dan Wewer citing increasing industry challenges. Wewer is concerned about increasing promotional activity and aggressive pricing tactics by competitors. 3. Cree (CREE) downgraded to Underweight from Equal Weight at Stephens. 4. Washington Prime (WPG) downgraded to Underperform from Neutral at Boenning & Scattergood by analyst Floris van Dijkum due to a more expensive NAV relative valuation caused by the more than 6% sector outperformance in the current quarter. 5. Baozun (BZUN) downgraded to Hold from Buy at Deutsche Bank by analyst Eileen Deng citing valuation after the stock's 18% rise in the past six months. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/23/17
DBAB
08/23/17
DOWNGRADE
Target $30
DBAB
Hold
Baozun downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Eileen Deng downgraded Baozun to Hold from Buy citing valuation after the stock's 18% rise in the past six months. Given the outsized advance, Deng feels the company's future catalysts are already reflected in its share price, she tells investors. However, she raised her price target on Baozun to $30 from $25.
TTWO Take-Two
$112.91

(0.00%)

05/17/18
BARD
05/17/18
NO CHANGE
Target $137
BARD
Outperform
Take-Two Q4 results likely impacted by Fortnite pressure, says Baird
Baird analyst Colin Sebastian noted Take-Two's Q4 results were below expectations, stating that was likely due to competitive pressure from Fortnite. He said the soft Q1 guidance also reflects the tough competitive landscape, but that expectations for its Red Dead title remain as guidance contemplates significant second half bookings. Sebastian reiterated his Outperform rating and $137 price target on Take-Two shares.
05/17/18
WEDB
05/17/18
NO CHANGE
Target $132
WEDB
Outperform
Take-Two shares continue to present 'compelling' value, says Wedbush
Wedbush analyst Michael Pachter raised his price target on Take-Two Interactive to $132 from $126 and maintained an Outperform rating on shares, telling investors in a research note that shares continue to present a "compelling" value following the company's Q4 results. Despite its lowered guidance, Pachter contended that Take-Two has a "clear path" for earnings growth ahead, and that the delay of the unannounced 2K title strengthens his confidence that the company can again grow earnings in fiscal 2020, as catalog sales of Red Dead Redemption 2, the launch of Borderlands 3 and growth from its core portfolio should allow Take-Two to grow its top line by 5% or more and EPS by 10% or more. Looking ahead, Pachter sees a new BioShock title, new Rockstar games, new titles from Private division and continued growth of recurring revenue.
05/17/18
KEYB
05/17/18
NO CHANGE
Target $152
KEYB
Overweight
Take-Two price target raised to $152 from $144 at KeyBanc
KeyBanc analyst Evan Wingren raised his price target for Take-Two Interactive Software to $152 saying the company's initial fiscal 2019 guidance is above expectations given the pushout of key game Borderlands. The analyst believes the valuation "too inexpensive" and recommends buying Take-Two shares with an Overweight rating.
05/17/18
BNCH
05/17/18
NO CHANGE
Target $135
BNCH
Buy
Take-Two price target raised to $135 from $130 at Benchmark
Benchmark analyst Mike Hickey raised his price target on Take-Two shares to $135 following the game maker's Q4 earnings report, stating that he remains impressed with the company's recent earnings power and expects "considerable" near-term growth driven by Red Dead Redemption 2 and continued positive digital trends. He maintains a Buy rating on Take-Two.
NTES NetEase
$266.00

(0.00%)

05/17/18
BNCH
05/17/18
NO CHANGE
Target $340
BNCH
Buy
NetEase price target lowered to $340 from $355 at Benchmark
Benchmark analyst Fawne Jiang lowered her price target on NetEase to $340 from $355, citing near-term margin pressure following the company's report of mixed Q1 results. While its revenue beat was mainly driven by the resumption of mobile gaming growth and continued momentum of the ecommerce businesses, NetEase's earnings underperformance was mainly due to higher operating expenses and higher copyrights related costs, said Jiang, who keeps a Buy rating on the stock.
04/25/18
LYON
04/25/18
UPGRADE
LYON
Outperform
NetEase upgraded to Outperform from Underperform at CLSA
CLSA upgraded NetEase to Outperform from Underperform, mainly citing valuation, adding that the company could see a rebound in gaming revenues in Q1.
04/12/18
JPMS
04/12/18
INITIATION
Target $240
JPMS
Underweight
NetEase resumed with an Underweight at JPMorgan
JPMorgan analyst Alex Yao resumed coverage of NetEase with an Underweight rating and $240 price target. Prior to restricting the stock in 2016, the firm had an Overweight rating on the shares. The analyst views 2018 as a transition year for NetEase in terms of game genre and geographic market. The biggest revenue driver of NetEase in the past few years, PC IP migration to mobile, "has already been exhausted," Yao tells investors in a research note. He believes NetEase is entering a "structurally less profitable stage" due to lower per gamer monetization.
04/10/18
JEFF
04/10/18
NO CHANGE
Target $310
JEFF
Hold
NetEase price target lowered to $310 from $335 at Jefferies
Jefferies analyst Karen Chan lowered her price target for NetEase to $310 from $335, while reiterating a Hold rating on the shares. The analyst remains long-term positive on its gaming franchise and expects mobile games to resume quarter over quarter growth in Q1, but notes she will need further evidence of either more new hits or newly-launched titles performing better in order to justify upside to her 20% FY18 mobile game growth forecast. Rising competition for gamer time spent, increased promotional effort and revenue mix change poses downside risk to FY18/19 consensus earnings, Chan contends.
CSCO Cisco
$45.16

(0.00%)

05/17/18
BARD
05/17/18
NO CHANGE
Target $51
BARD
Outperform
Cisco weakness a buying opportunity, says Baird
Baird analyst Jayson Noland said Cisco posted a solid quarter on nearly all metrics and recommended buying the dip in the shares. The analyst said the selloff was due in part to high expectations against its in-line Q4 guidance. Noland reiterated his Outperform rating and $51 price target on Cisco shares.
05/17/18
JMPS
05/17/18
NO CHANGE
JMPS
Market Perform
Cisco results bode well for Arista, Nutanix and Palo Alto, says JMP Securities
JMP Securities analyst Erik Suppiger said Cisco (CSCO) noted strength in data center and campus switching in its Q3 earnings report, which suggests to him that demand trends are favorable for Arista Networks (ANET). In the DC business, Cisco noted it grew double digits year-over-year driven by its hyperconverged infrastructure product, which Suppiger sees pointing to favorable demand for Nutanix (NTNX). Additionally, security sales re-accelerated in the quarter to double-digit growth for the first time in over a year, which the analyst reads as a favorable trend for Palo Alto Networks (PANW). On Cisco itself, Suppiger said he sees the stock as fairly valued and he maintains a Market Perform rating on the shares.
05/17/18
MSCO
05/17/18
NO CHANGE
Target $50
MSCO
Overweight
Cisco laying groundwork for upside in FY19, says Morgan Stanley
Following Cisco's report of "strong" Q3 results and "generally positive" comments from management regarding the outlook, Morgan Stanley analyst James Faucette said the earnings call "offered ample evidence" Cisco's software strategy is progressing well. He sees software helping to stabilize equipment replacement cycles and believes the stock will approach $50 as the market becomes more convinced FY19 estimates are too low. Faucette maintains an Overweight rating and $50 price target on Cisco shares.
05/17/18
RBCM
05/17/18
NO CHANGE
Target $50
RBCM
Outperform
Cisco post-earnings stock dip is a buying opportunity, says RBC Capital
RBC Capital analyst Mitch Steves kept his Outperform rating and $50 price target on Cisco, saying the slight pullback in the stock price following the in-line earnings and guidance may be a buying opportunity. The analyst cites continued growth in deferred revenues while also forecasting growth in Switching sales for 2-3 quarters given the backlog and its high margin levels. Steves also notes Cisco's history of buybacks when its stock price traded in $42-$44 per share range, creating a "nice support for the stock".
RSX Market Vectors Russia ETF
$21.69

(0.00%)

SDRL Seadrill
$0.47

(0.00%)

05/31/17
SOCG
05/31/17
DOWNGRADE
SOCG
Sell
Seadrill downgraded to Sell from Hold at Societe Generale
Societe Generale analyst Guillaume Delaby downgraded Seadrill to Sell from Hold saying shareholders will likely receive minimal recovery for their existing shares when the financial restructuring plan is finalized.
WMT Walmart
$86.07

(0.00%)

05/15/18
SPHN
05/15/18
NO CHANGE
Target $108
SPHN
Overweight
Walmart Q1 expectations achievable, says Stephens
Stephens analyst Ben Bienvenu said he believes that consensus expectations regarding Walmart's Q1 results are achievable, though he noted that e-commerce growth in the quarter may come in below the company's annual guidance for about 40% growth. Still, easier e-commerce comparisons as the year progresses make its annual goals doable and Bienvenu remains confident that Walmart is one of the best positioned retailers he covers, he tells investors. He maintains an Overweight rating and $108 price target on Walmart ahead of the company's earnings report due on Thursday.
05/17/18
BARD
05/17/18
NO CHANGE
Target $95
BARD
Outperform
Walmart Q1 results all in all very positive, says Baird
Baird analyst Peter Benedict noted Walmart reported Q1 results which beat both his and Street estimates. The analyst said results were driven by higher sales and better gross margins, but noted comps were a touch light, citing seasonal trends in April. He said the results were positive overall with better sales, gross margins, and e-commerce acceleration outweighing the slight U.S. comp deceleration. Benedict reiterated his Outperform rating and $95 price target on Walmart shares.
05/16/18
MKMP
05/16/18
NO CHANGE
Target $93
MKMP
Buy
Target to benefit from strong digital sales, says MKM Partners
MKM Partners analyst Patrick McKeever kept his Buy rating and $93 price target on Target Corp (TGT) ahead of its Q1 earnings next week. The analyst says the aggressive Street consensus for earnings is "doable" in spite of the negative impact from cold weather in the East, noting that the quarter will likely see more strong growth in digital sales driven by more "expedient" fulfillment and new orders. McKeever adds that despite the 12% run in the stock price year-to-date, its valuation is still 3.4 points below that of Walmart (WMT) on "overly pessimistic" investor sentiment. The analyst says Target remains his "Top Pick" in the space in 2018.
05/10/18
LOOP
05/10/18
NO CHANGE
Target $87
LOOP
Hold
Walmart price target lowered to $87 from $92 at Loop Capital
Loop Capital analyst Andrew Wolf lowered his price target on Walmart to $87 and kept his Hold rating after the company's $16B investment in Flipkart. The analyst is positive on the deal longer term, given that India's retail market is expected to grow at 9% per year over the next 5 years and in light of the company's minimal store presence in India. In the medium term however, Wolf says the investment will be "meaningfully dilutive" to earnings, weighing on the stock.
CHK Chesapeake
$3.94

(0.00%)

03/07/18
UBSW
03/07/18
INITIATION
Target $2.8
UBSW
Sell
Chesapeake initiated with a Sell at UBS
UBS analyst Lloyd Byrne started Chesapeake Energy with a Sell rating and $2.80 price target.
03/26/18
BERN
03/26/18
DOWNGRADE
BERN
Underperform
Chesapeake downgraded to Underperform from Market Perform at Bernstein
03/27/18
03/27/18
DOWNGRADE

Underperform
Chesapeake downgraded to Underperform at Bernstein
As previously reported, Bernstein analyst Bob Brackett downgraded Chesapeake to Underperform from Market Perform as he believes gas levered names, particularly those with significant debt loads, are likely to struggle as gas prices compress cash margins.
04/17/18
SBSH
04/17/18
DOWNGRADE
Target $2
SBSH
Sell
Chesapeake downgraded to Sell from Neutral at Citi
Citi analyst Robert Morris downgraded Chesapeake Energy to Sell and lowered his price target for the shares to $2 from $5. The analyst made a series of downgrades after lowering his 2018 composite spot natural gas price forecast to $2.75/MMBtu from $3.00/MMBtu, and for 2019 to $2.60/MMBtu from $3.35/MMBtu. He sees higher oil prices adversely impacting the outlook for U.S. natural gas prices.
BIDU Baidu
$283.88

(0.00%)

05/11/18
05/11/18
UPGRADE

Market Perform
Baidu upgraded to Market Perform from Underperform at Bernstein
As previously reported, Bernstein analyst Bhavtosh Vajpayee upgraded Baidu to Market Perform from Underperform and raised his price target on shares to $305 from $240, saying "a 20% growth prognosis with an equivalent earnings expansion CAGR deserves more credit than our earlier Underperform rating."
05/11/18
BERN
05/11/18
UPGRADE
BERN
Market Perform
Baidu upgraded to Market Perform from Underperform at Bernstein
05/08/18
GSCO
05/08/18
INITIATION
Target $319
GSCO
Buy
Baidu reinstated with a Buy at Goldman Sachs
Goldman analyst Piyush Mubayi reinstated Baidu with a Buy and $319 price target citing a re-acceleration in core search, improved capital allocation, and progress in DuerOS autonomous driving project with Apollo.
04/30/18
04/30/18
NO CHANGE
Target $310

Outperform
Baidu price target raised to $310 from $300 at Wells Fargo
Wells Fargo analyst Ken Sena raised his price target for Baidu to $310 from $300 after the company delivered a "strong" Q2 guide on an otherwise "solid" Q1 results. The analyst reiterates an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

AERI

Aerie Pharmaceuticals

$58.50

0.1 (0.17%)

, AGN

Allergan

$191.34

-1.11 (-0.58%)

04:55
09/23/18
09/23
04:55
09/23/18
04:55
Conference/Events
European Society of Retina Specialists to hold a conference »

18th Congress of EURETINA…

AERI

Aerie Pharmaceuticals

$58.50

0.1 (0.17%)

AGN

Allergan

$191.34

-1.11 (-0.58%)

ALIM

Alimera Sciences

$1.07

(0.00%)

BABY

Natus Medical

$34.45

-0.2 (-0.58%)

BHC

Bausch Health

$24.92

-0.07 (-0.28%)

BAYRY

Bayer

$0.00

(0.00%)

ELXMF

Ellex Medical Lasers

$0.00

(0.00%)

GKOS

Glaukos

$58.78

-1.69 (-2.79%)

IRIX

IRIDEX

$6.52

0.08 (1.24%)

JNJ

Johnson & Johnson

$142.85

0.85 (0.60%)

NITE

Nightstar Therapeutics

$25.64

-1.71 (-6.25%)

NVS

Novartis

$85.46

-0.505 (-0.59%)

OCUL

Ocular Therapeutix

$6.45

0.03 (0.47%)

RHHBY

Roche

$0.00

(0.00%)

SHPG

Shire

$178.32

-1.68 (-0.93%)

STAA

STAAR Surgical

$47.00

-0.9 (-1.88%)

TMDI

Titan Medical

$2.24

0.02 (0.90%)

TTNP

Titan Pharmaceuticals

$0.22

-0.2833 (-56.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 24

    Sep

  • 25

    Sep

  • 27

    Sep

  • 01

    Oct

  • 03

    Oct

  • 09

    Oct

  • 16

    Oct

  • 22

    Oct

  • 28

    Oct

  • 29

    Oct

  • 15

    Nov

  • 27

    Nov

  • 21

    Dec

  • 28

    Dec

  • 15

    Feb

  • 25

    Feb

CMCSA

Comcast

$37.91

0.1 (0.26%)

, CMCSK

Comcast

$0.00

(0.00%)

14:32
09/22/18
09/22
14:32
09/22/18
14:32
Periodicals
Comcast outbids Fox in battle for Sky, Reuters reports »

Comcast (CMCSA; CMCSK)…

CMCSA

Comcast

$37.91

0.1 (0.26%)

CMCSK

Comcast

$0.00

(0.00%)

FOX

21st Century Fox

$43.97

-0.23 (-0.52%)

FOXA

21st Century Fox

$44.33

-0.26 (-0.58%)

SKYAY

Sky

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BOKF

BOK Financial

$104.69

-0.08 (-0.08%)

, COBZ

CoBiz Financial

$23.44

0.01 (0.04%)

13:36
09/22/18
09/22
13:36
09/22/18
13:36
Conference/Events
CoBiz Financial to host special shareholder meeting »

Special Shareholder…

BOKF

BOK Financial

$104.69

-0.08 (-0.08%)

COBZ

CoBiz Financial

$23.44

0.01 (0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 27

    Sep

AMRH

AMERI Holdings

$1.44

-0.04 (-2.70%)

13:30
09/22/18
09/22
13:30
09/22/18
13:30
Conference/Events
AMERI Holdings to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

BRK.A

Berkshire Hathaway

$331,710.00

-1090 (-0.33%)

13:26
09/22/18
09/22
13:26
09/22/18
13:26
Periodicals
Berkshire Hathaway still looks underpriced, Barron's says »

Class A shares of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLGO

BioLargo

$0.00

(0.00%)

13:11
09/22/18
09/22
13:11
09/22/18
13:11
Conference/Events
BioLargo to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CZWI

Citizens Community Bancorp

$14.13

0.03 (0.21%)

12:56
09/22/18
09/22
12:56
09/22/18
12:56
Conference/Events
Citizens Community Bancorp to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SF

Stifel Financial

$54.86

-0.78 (-1.40%)

12:50
09/22/18
09/22
12:50
09/22/18
12:50
Conference/Events
Stifel Financial to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBCT

People's United

$17.94

-0.055 (-0.31%)

, FBNK

First Connecticut

$30.95

0.1 (0.32%)

12:47
09/22/18
09/22
12:47
09/22/18
12:47
Conference/Events
First Connecticut to host special shareholder meeting »

Special shareholder…

PBCT

People's United

$17.94

-0.055 (-0.31%)

FBNK

First Connecticut

$30.95

0.1 (0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 18

    Oct

ASPS

Altisource

$34.10

-0.09 (-0.26%)

12:44
09/22/18
09/22
12:44
09/22/18
12:44
Conference/Events
Altisource to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$217.65

-2.35 (-1.07%)

, CSCO

Cisco

$48.51

0.77 (1.61%)

12:36
09/22/18
09/22
12:36
09/22/18
12:36
Periodicals
Apple, Microsoft among stocks with solid dividends, Barron's says »

Technology stocks are not…

AAPL

Apple

$217.65

-2.35 (-1.07%)

CSCO

Cisco

$48.51

0.77 (1.61%)

IBM

IBM

$151.29

0.12 (0.08%)

MSFT

Microsoft

$114.70

1.13 (0.99%)

ORCL

Oracle

$51.08

0.65 (1.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 25

    Sep

  • 26

    Sep

  • 26

    Sep

  • 26

    Sep

  • 27

    Sep

  • 03

    Oct

  • 04

    Oct

  • 05

    Oct

  • 10

    Oct

  • 21

    Oct

  • 22

    Oct

  • 22

    Oct

  • 24

    Oct

  • 25

    Oct

  • 28

    Oct

  • 28

    Nov

  • 03

    Mar

CAT

Caterpillar

$156.39

0.38 (0.24%)

, AMAT

Applied Materials

$39.62

0.22 (0.56%)

12:28
09/22/18
09/22
12:28
09/22/18
12:28
Periodicals
Caterpillar, KeyCorp among stocks to buy as bond yields rise, Barron's says »

As the economy improves,…

CAT

Caterpillar

$156.39

0.38 (0.24%)

AMAT

Applied Materials

$39.62

0.22 (0.56%)

BWA

BorgWarner

$45.24

-0.53 (-1.16%)

KEY

KeyCorp

$20.78

0.02 (0.10%)

PH

Parker-Hannifin

$190.52

0.01 (0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Sep

  • 18

    Oct

  • 25

    Oct

  • 30

    Oct

BSX

Boston Scientific

$37.76

-0.07 (-0.19%)

, ISRG

Intuitive Surgical

$556.70

-4.43 (-0.79%)

10:34
09/22/18
09/22
10:34
09/22/18
10:34
Periodicals
'Good time' to think about device markers, Barron's says »

Medical technology stocks…

BSX

Boston Scientific

$37.76

-0.07 (-0.19%)

ISRG

Intuitive Surgical

$556.70

-4.43 (-0.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Oct

TLRY

Tilray

$123.16

-53.365 (-30.23%)

10:20
09/22/18
09/22
10:20
09/22/18
10:20
Periodicals
Marijuana stocks 'the new Bitcoin,' Barron's says »

Led by Tilray, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$217.65

-2.35 (-1.07%)

, WMT

Walmart

$95.85

0.1 (0.10%)

09:05
09/22/18
09/22
09:05
09/22/18
09:05
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AAPL

Apple

$217.65

-2.35 (-1.07%)

WMT

Walmart

$95.85

0.1 (0.10%)

DE

Deere

$152.82

-1.24 (-0.80%)

AGCO

Agco

$60.24

-0.9 (-1.47%)

ADM

Archer Daniels

$50.33

(0.00%)

MOS

Mosaic

$32.33

0.02 (0.06%)

CF

CF Industries

$52.82

-0.48 (-0.90%)

SPWR

SunPower

$7.88

-0.18 (-2.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 28

    Oct

  • 06

    Nov

  • 13

    Nov

  • 15

    Nov

  • 03

    Mar

AERI

Aerie Pharmaceuticals

$58.50

0.1 (0.17%)

, AGN

Allergan

$191.34

-1.11 (-0.58%)

04:55
09/22/18
09/22
04:55
09/22/18
04:55
Conference/Events
European Society of Retina Specialists to hold a conference »

18th Congress of EURETINA…

AERI

Aerie Pharmaceuticals

$58.50

0.1 (0.17%)

AGN

Allergan

$191.34

-1.11 (-0.58%)

ALIM

Alimera Sciences

$1.07

(0.00%)

BABY

Natus Medical

$34.45

-0.2 (-0.58%)

BHC

Bausch Health

$24.92

-0.07 (-0.28%)

BAYRY

Bayer

$0.00

(0.00%)

ELXMF

Ellex Medical Lasers

$0.00

(0.00%)

GKOS

Glaukos

$58.78

-1.69 (-2.79%)

IRIX

IRIDEX

$6.52

0.08 (1.24%)

JNJ

Johnson & Johnson

$142.85

0.85 (0.60%)

NITE

Nightstar Therapeutics

$25.64

-1.71 (-6.25%)

NVS

Novartis

$85.46

-0.505 (-0.59%)

OCUL

Ocular Therapeutix

$6.45

0.03 (0.47%)

RHHBY

Roche

$0.00

(0.00%)

SHPG

Shire

$178.32

-1.68 (-0.93%)

STAA

STAAR Surgical

$47.00

-0.9 (-1.88%)

TMDI

Titan Medical

$2.24

0.02 (0.90%)

TTNP

Titan Pharmaceuticals

$0.22

-0.2833 (-56.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 24

    Sep

  • 25

    Sep

  • 27

    Sep

  • 01

    Oct

  • 03

    Oct

  • 09

    Oct

  • 16

    Oct

  • 22

    Oct

  • 28

    Oct

  • 29

    Oct

  • 15

    Nov

  • 27

    Nov

  • 21

    Dec

  • 28

    Dec

  • 15

    Feb

  • 25

    Feb

CDTI

CDTi

$0.34

0.01 (3.08%)

18:15
09/21/18
09/21
18:15
09/21/18
18:15
Hot Stocks
CDTi sees September 21 as effective date of reverse stock split »

CDTi Advanced Materials…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DUK

Duke Energy

$79.82

-0.81 (-1.00%)

18:08
09/21/18
09/21
18:08
09/21/18
18:08
Hot Stocks
Duke Energy restored nearly 1.8M outages in NC, SC during past week »

Duke Energy crews today…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 02

    Oct

  • 03

    Oct

  • 04

    Oct

  • 11

    Nov

JNJ

Johnson & Johnson

$142.85

0.85 (0.60%)

18:01
09/21/18
09/21
18:01
09/21/18
18:01
Hot Stocks
Johnson & Johnson's Janssen discloses phase 3 study results of Esketamine »

The Janssen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 28

    Oct

UAL

United Continental

$89.94

0.8 (0.90%)

17:39
09/21/18
09/21
17:39
09/21/18
17:39
Periodicals
United pilots refuse contract changes on regional routes, Reuters says »

United Airlines pilots…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

XLE

Energy Select Sector SPDR

$75.11

0.5132 (0.69%)

, XLU

Utilities SPDR

$53.04

0.2049 (0.39%)

17:36
09/21/18
09/21
17:36
09/21/18
17:36
General news
Week ending ETF Scorecard: Materials outperform, Utlilites slump »

S&P500 SECTORS:…

XLE

Energy Select Sector SPDR

$75.11

0.5132 (0.69%)

XLU

Utilities SPDR

$53.04

0.2049 (0.39%)

IYR

DJ US Real Estate Index Fund

$81.88

-0.06 (-0.07%)

XLP

Consumer Staples Sector SPDR

$55.02

0.1285 (0.23%)

XLY

Consumer Discretionary Sector SPDR

$116.98

-0.4288 (-0.37%)

XLB

S&P Select Materials SPDR

$60.54

-0.1312 (-0.22%)

XLF

Financial Select Sector

$28.73

-0.1175 (-0.41%)

XLV

Health Care Select Sector SPDR

$94.26

0.1571 (0.17%)

XLK

Technology Select Sector SPDR

$74.68

-0.2056 (-0.27%)

XLI

Industrial Select Sector SPDR

$79.71

0.2338 (0.29%)

GLD

SPDR Gold Trust

$113.48

-0.77 (-0.67%)

SLV

iShares Silver Trust

$13.44

-0.01 (-0.07%)

USO

United States Oil Fund

$14.95

0.145 (0.98%)

UNG

United States Natural Gas Fund

$24.60

0.235 (0.96%)

HYG

iShares iBoxx $ High Yield Corporate Bond

$86.24

0.05 (0.06%)

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$114.72

0.04 (0.03%)

TLT

iShares 20+ Year Treasury Bond Fund

$117.12

-0.02 (-0.02%)

IEF

iShares 7-10 Year Treasury Bond ETF

$101.00

0.03 (0.03%)

SHY

iShares 1-3 Year Treasury Bond

$83.05

0.02 (0.02%)

IWD

iShares Russell 1000 Value

$129.51

0.13 (0.10%)

IWF

iShares Russell 1000 Growth

$155.30

-0.55 (-0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OHGI

One Horizon Group

$0.18

-0.0088 (-4.63%)

17:34
09/21/18
09/21
17:34
09/21/18
17:34
Syndicate
Breaking Syndicate news story on One Horizon Group »

One Horizon Group files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYTX

Cytori Therapeutics

$0.41

-0.033 (-7.38%)

17:31
09/21/18
09/21
17:31
09/21/18
17:31
Syndicate
Breaking Syndicate news story on Cytori Therapeutics »

Cytori Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEM

Newmont Mining

$31.56

0.05 (0.16%)

17:22
09/21/18
09/21
17:22
09/21/18
17:22
Syndicate
Breaking Syndicate news story on Newmont Mining »

Newmont Mining files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 25

    Oct

CB

Chubb

$139.87

-0.05 (-0.04%)

17:22
09/21/18
09/21
17:22
09/21/18
17:22
Hot Stocks
Chubb CEO Greenberg sells $8.6M in common stock »

Chubb CEO Evan Greenberg…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.